| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/02/2011 | EP2046748B1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 03/02/2011 | EP1885382B1 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 03/02/2011 | EP1884236B1 Angiogenesis inhibitor containing amine derivative as active ingredient |
| 03/02/2011 | EP1740699B1 Connexin 40 tissue specific gene mutations |
| 03/02/2011 | EP1686951B1 Combined cosmetic or therapeutic preparation |
| 03/02/2011 | EP1656131B1 Use of betaine for treating intermittent claudication |
| 03/02/2011 | EP1638552B1 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer |
| 03/02/2011 | EP1383761B1 Phenyl- and pyridyl-piperidines with tnf activity |
| 03/02/2011 | EP1163337B1 Vascular adhesion molecules and modulation of their function |
| 03/02/2011 | EP1103269B1 Use of HGF for the treatment of ischemic diseases of the extremities |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/02/2011 | CN1832965B Endothelial cell specific antibodies and uses thereof |
| 03/02/2011 | CN1568195B Peptide YY and peptide YY agonists for treatment of metabolic disorders |
| 03/02/2011 | CN101983065A Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 03/02/2011 | CN101983056A Preventive and/or remedy for vascular diseases |
| 03/02/2011 | CN101982775A Drug screening method based on cell fluorescent images |
| 03/02/2011 | CN101982189A Method for detecting salvia heart-soothing capsules |
| 03/02/2011 | CN101982184A Preparation method of taraxacum extract |
| 03/02/2011 | CN101982175A Application of pedunculoside in preparing medicine for treating cerebral ischemia |
| 03/02/2011 | CN101982172A Combined drug of Ginkgolide and Ginkgo flavone as well as preparation and application thereof |
| 03/02/2011 | CN101249169B Mongolian medicine for curing hemorrhoid |
| 03/02/2011 | CN101193656B Novel triglyceride reducing agent |
| 03/02/2011 | CN101099758B Compound gingko leaves preparation and its preparing process |
| 03/02/2011 | CN101084889B Ginkgolide freezing-dried powder injection and preparation method thereof |
| 03/01/2011 | US7897763 Process for the preparation of substituted phenylalanines |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897644 Antiinflammatory agents; analgesics |
| 03/01/2011 | US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897615 Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors |
| 03/01/2011 | US7897610 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction |
| 03/01/2011 | US7897594 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | CA2437240C Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 03/01/2011 | CA2217820C Milk and milk products for preventing or treating heart disease |
| 02/24/2011 | WO2011022334A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
| 02/24/2011 | WO2011022071A2 Cardiac compositions |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2011021594A1 Sustained drug delivery system |
| 02/24/2011 | WO2011020193A1 Renin inhibitors |
| 02/24/2011 | WO2010146187A3 Process for the preparation of telmisartan |
| 02/24/2011 | WO2010136508A3 Stem cell targeting |
| 02/24/2011 | WO2010086860A3 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/24/2011 | WO2010078900A3 Novel aliphatically substituted pyrazolopyridines, and the use thereof |
| 02/24/2011 | WO2010077339A3 β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 02/24/2011 | WO2010009120A8 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
| 02/24/2011 | US20110046722 Oxazinyl isoflavonoid compounds, medicaments and use |
| 02/24/2011 | US20110046599 Multi-Day Delivery Of Biologically Active Substances |
| 02/24/2011 | US20110046546 Methods for treating headaches |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046234 Retinaldehyde in the Treatment of Obesity, Diabetes and Other Conditions |
| 02/24/2011 | US20110046221 Therapeutic intervention to mimic the effect of caloric restriction |
| 02/24/2011 | US20110046192 Therapeutic drug for hypertension or prehypertension |
| 02/24/2011 | US20110046188 Compositions comprising novel ppar ligands and anti-hyperlipemic agents |
| 02/24/2011 | US20110046187 Assessing congestive heart risk in patients treated or potentially to be treated with a peroxisome-proliferator-activator-receptor-gamma agonist or a thiazolidinedione |
| 02/24/2011 | US20110046182 Efficient aspirin prodrugs |
| 02/24/2011 | US20110046177 Therapeutic quinoline and naphthalene derivatives |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046162 Fused cyanopyridines and the use thereof |
| 02/24/2011 | US20110046158 Capped pyrazinoylguanidine sodium channel blockers |
| 02/24/2011 | US20110046151 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 02/24/2011 | US20110046150 Use of n--4-(3-pyridyl)-2-pyridine-amine for the treatment of pulmonary hypertension |
| 02/24/2011 | US20110046142 Antibiotic compounds |
| 02/24/2011 | US20110046139 Benzocycloheptane and benzoxepine derivatives |
| 02/24/2011 | US20110046135 New compounds i |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046130 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 02/24/2011 | US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators |
| 02/24/2011 | US20110046126 Use of 2,4-Pyrimidinediamines For the Treatment of Atherosclerosis |
| 02/24/2011 | US20110046122 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines |
| 02/24/2011 | US20110046119 Therapeutic treatment |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046108 Pyrimidine derivatives |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110046090 Modulation of neurogenesis with gaba agents and gaba analogs |
| 02/24/2011 | US20110046089 Substituted 2-phenyl-pyridine derivatives |
| 02/24/2011 | US20110046087 Pharmaceutical composition, methods for treating and uses thereof |
| 02/24/2011 | US20110046079 Use of Proton Pump Inhibitors as Drug Delivery Adjuvants |
| 02/24/2011 | US20110046076 Pharmaceutical composition, methods for treating and uses thereof |
| 02/24/2011 | US20110046063 Ready-to-use bivalirudin compositions |
| 02/24/2011 | US20110046056 Apoa-1 peptide mimetics |
| 02/24/2011 | US20110045111 Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases |
| 02/24/2011 | US20110045097 Solid pharmaceutical composition comprising irbesartan |
| 02/24/2011 | US20110045091 Anti-angiogenesis, anticancer proliferation properties of lymphocytic-derived microparticles |
| 02/24/2011 | US20110045090 Formulations of flibanserin |
| 02/24/2011 | US20110045061 Gene therapy for diabetic ischemic disease |
| 02/24/2011 | US20110045055 Medical devices containing therapeutic agents |
| 02/24/2011 | US20110045054 Materials and methods for treating and managing plaque disease |
| 02/24/2011 | US20110045035 Methods of treating ophthalmic disorders |
| 02/24/2011 | US20110045028 Sustained release preparation |
| 02/24/2011 | US20110045014 Acceleration agent of calcium absorption |
| 02/24/2011 | US20110045012 Anti-atheroma vaccine |
| 02/24/2011 | US20110044997 Methods |
| 02/24/2011 | US20110044988 Methods of treatment using anti-mif antibodies |
| 02/24/2011 | US20110044971 Method and composition for treating a seratonin receptor-mediated condition |
| 02/24/2011 | US20110044957 Methods and systems for extended in vitro culture of neuronal cells |